Copyright: ©Author(s) 2026.
World J Clin Oncol. Oct 24, 2026; 17(10): 124301
Published online Oct 24, 2026. doi: 10.5306/wjco.124301
Published online Oct 24, 2026. doi: 10.5306/wjco.124301
Table 4 Interaction analysis
| Subgroup | HR | 95%CI | P value | P for interaction |
| Sex (male) | 0.528 | 0.296-0.941 | 0.030 | 0.003 |
| Sex (female) | 1.676 | 1.014-2.770 | 0.044 | 0.003 |
| Gene type (wild type) | 0.467 | 0.236-0.922 | 0.028 | 0.005 |
| Gene type (mutant) | 1.463 | 0.989-2.163 | 0.057 | 0.005 |
| Prior treatment (third-line or later) | 2.175 | 1.389-3.407 | 0.001 | 0.005 |
| TCM deficiency - liver qi stagnation with spleen deficiency | 0.465 | 0.244-0.887 | 0.020 | 0.014 |
| KPS < 80 | 2.492 | 1.317-4.717 | 0.005 | 0.058 |
- Citation: Li R, Xu YY, Wu BB, Wang MM, Guan L, Li BR, Wang YW, Yang YF, Pang B. Clinical efficacy of integrated Chinese-Western medicine therapy for metastatic colorectal cancer. World J Clin Oncol 2026; 17(10): 124301
- URL: https://www.wjgnet.com/2218-4333/full/v17/i10/124301.htm
- DOI: https://dx.doi.org/10.5306/wjco.124301